, Tracking Stock Market Picks
Enter Symbol:
Aegerion Pharmaceuticals, Inc. (AEGR) [hlAlert]

up 49.24 %

Aegerion Pharmaceuticals Inc. (AEGR) rated Buy with price target $16 by Collins Stewart

Posted on: Monday,  Dec 6, 2010  12:25 PM ET by Collins Stewart

Collins Stewart rated Buy Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) on 12/06/2010, when the stock price was $11.90. Since
then, Aegerion Pharmaceuticals, Inc. has gained 49.24% as of 01/27/2016's recent price of $17.76.
If you would have followed this Collins Stewart's recommendation on AEGR, you would have gained 49.24% of your investment in 1878 days.

Aegerion Pharmaceuticals, Inc. (Aegerion) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat severe lipid disorders. Its lead compound, lomitapide, is a microsomal triglyceride transfer protein inhibitor (MTP-I), which limits secretion of cholesterol and triglycerides from the intestines and the liver, the main sources of lipids in the body. The Company is initially developing lomitapide as an oral, once-a-day treatment for patients with a rare genetic lipid disorder called homozygous familial hypercholesterolemia (HoFH). HoFH is a genetic lipid disorder caused by defects in both copies of the low-density lipoprotein (LDL) receptor genes, resulting in impaired or total loss of function in the LDL receptor.

Collins Stewart's research department is built around a number of sector-specialist teams. Our analysts are leaders in their area of specialisation and combine deep industry knowledge with decades of stock broking experience to produce insightful, independent sector research. Our research approach encompasses Questâ„¢ principles and focuses on cash-driven valuation techniques. Research is a Collins Stewart cornerstone; it is leveraged throughout the organisation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/6/2010 12:25 PM Buy
11.90 16.00
as of 12/31/2010
1 Week down  -15.75 %
1 Month down  -17.00 %
3 Months   
1 YTD down  -17.00 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy